<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?origin publisher?>
  <?FILEmeta_YMVRE2816 xml ?>
  <?FILEmain xml ?>
  <?FILEgr1 jpg ?>
  <?FILEgr2 jpg ?>
  <?FILEgr3 jpg ?>
  <?FILEgr4 jpg ?>
  <?FILEgr5 jpg ?>
  <?FILEgr6 jpg ?>
  <?FILEgr7 jpg ?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Microvasc Res</journal-id>
      <journal-title>Microvascular Research</journal-title>
      <issn pub-type="ppub">0026-2862</issn>
      <issn pub-type="epub">1095-9319</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2666799</article-id>
      <article-id pub-id-type="pmid">18721820</article-id>
      <article-id pub-id-type="publisher-id">YMVRE2816</article-id>
      <article-id pub-id-type="doi">10.1016/j.mvr.2008.07.006</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Regular Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Low-frequency blood flow oscillations in congestive heart failure and after &#x3B2;1-blockade treatment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bernjak</surname>
            <given-names>A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Clarkson</surname>
            <given-names>P.B.M.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McClintock</surname>
            <given-names>P.V.E.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stefanovska</surname>
            <given-names>A.</given-names>
          </name>
          <email>aneta@lancaster.ac.uk</email>
          <xref rid="aff3" ref-type="aff">c</xref>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>a</sup>Faculty of Electrical Engineering, University of Ljubljana, Slovenia</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>b</sup>Cardiology Department, Royal Lancaster Infirmary, LA1 4RP, UK</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>c</sup>Physics Department, Lancaster University, LA1 4YB, UK</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>&#x204E;</label>Corresponding author. Faculty of Electrical Engineering, University of Ljubljana, Slovenia. Fax: +44 1524 844037. <email>aneta@lancaster.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <volume>76</volume>
      <issue>3-2</issue>
      <fpage>224</fpage>
      <lpage>232</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>6</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>7</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>7</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 Elsevier Inc.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>Laser Doppler flowmetry (LDF) of forearm skin blood flow, combined with iontophoretically-administered acetylcholine and sodium nitroprusside and wavelet spectral analysis, was used for noninvasive evaluation of endothelial function in 17 patients newly diagnosed with New York Heart Association class II&#x2013;III congestive heart failure (CHF). After 20&#xA0;&#xB1;&#xA0;10&#xA0;weeks' treatment with a &#x3B2;<sub>1</sub>-blocker (Bisoprolol), the measurements were repeated. Measurements were also made on an age- and sex-matched group of healthy controls (HC). In each case data were recorded for 30&#xA0;min. In HC, the difference in absolute spectral amplitude of LDF oscillations between the two vasodilators manifests in the frequency interval 0.005&#x2013;0.0095&#xA0;Hz (<italic>p</italic>&#xA0;&lt;&#xA0;0.01); this difference is initially absent in patients with CHF, but appears following the &#x3B2;<sub>1</sub>-blocker treatment (<italic>p</italic>&#xA0;&lt;&#xA0;0.01). For HC, the difference between the two vasodilators also manifests in normalised spectral amplitude in 0.0095&#x2013;0.021&#xA0;Hz (<italic>p</italic>&#xA0;&lt;&#xA0;0.05). This latter difference is absent in CHF patients and is unchanged by treatment with &#x3B2;<sub>1</sub>-blockers. It is concluded that there are two oscillatory skin blood flow components associated with endothelial function. Both are reduced in CHF. Activity in the lower frequency interval is restored by &#x3B2;<sub>1</sub>-blocker treatment, confirming the association between CHF and endothelial dysfunction but suggesting the involvement of two distinct mechanisms.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Blood flow oscillations</kwd>
        <kwd>Congestive heart failure</kwd>
        <kwd>&#x3B2;<sub>1</sub>-blockers</kwd>
        <kwd>Iontophoresis</kwd>
        <kwd>Laser Doppler flowmetry</kwd>
        <kwd>Wavelet transform</kwd>
        <kwd>Logarithmic frequency resolution</kwd>
        <kwd>Dynamics</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Congestive heart failure (CHF) is a complex clinical condition, in which the history of its management reflects the evolving understanding of its pathophysiology. CHF is associated with a typical neurohormonal response involving activation of both the renin&#x2013;angiotensin system and the sympathetic nervous system. This activation is deleterious and current therapeutic strategies to block the effects of this activation e.g. with angiotensin converting enzyme inhibitors (<xref rid="bib19" ref-type="bibr">Eichhorn and Bristow, 1996</xref>) and &#x3B2;-adrenergic blocking agents (<xref rid="bib12 bib50" ref-type="bibr">Bristow, 2000; L&#xF3;pez-Send&#xF3;n et al., 2004</xref>) have been clearly demonstrated to benefit favourably the poor outcome in all grades of severity of the condition. The results seen with &#x3B2;-blockade are particularly effective in producing a long-term reduction in mortality from both sudden death, and progressive cardiac failure, and improving symptomatology. Despite 30&#xA0;years of research the mode of action of &#x3B2;-blockers is still incompletely understood. It is likely that they act through multiple mechanisms including reducing tendencies to malignant dysrhythmias, and favourable effects on reverse remodeling (<xref rid="bib62 bib70" ref-type="bibr">Silke, 2006; Udelson, 2004</xref>).</p>
      <p>The endothelium plays a pivotal role in regulating blood flow by releasing relaxing and constricting factors, a role that has been shown to be impaired in CHF (<xref rid="bib18 bib73 bib54" ref-type="bibr">Drexler et al., 1992; Vanhoutte, 1996; Morgan et al., 2004</xref>). One of the mechanisms by which this occurs is through decreased peripheral production of endothelium-derived nitric oxide (NO) (<xref rid="bib37 bib76" ref-type="bibr">Katz et al., 1999; Zhao et al., 1996</xref>), possibly because of reduced shear stress due to reduced peripheral perfusion (<xref rid="bib17" ref-type="bibr">Drexler, 1998</xref>). Endothelial dysfunction in CHF has recently been shown to be associated with an increased mortality risk (<xref rid="bib36" ref-type="bibr">Katz et al., 2005</xref>). In isolated cellular models, direct effect of &#x3B2;-blockers has been shown on endothelial function and was suggested to at least partially explain the efficacy of beta-blockers in the treatment of advanced heart failure (<xref rid="bib22" ref-type="bibr">Garlichs et al., 1999</xref>).</p>
      <p>Various techniques are available to evaluate endothelial function, including brachial arterial imaging (<xref rid="bib40" ref-type="bibr">Kuvin and Karas, 2003</xref>), or plethysmography and laser Doppler flowmetry (LDF) (<xref rid="bib15" ref-type="bibr">Cracowski et al., 2006</xref>) that monitor vasodilatory responses to the administration of an endothelial-dependent vasodilator such as acetylcholine (ACh). A decreased response to ACh but not to the endothelial-independent vasodilator sodium nitroprusside (SNP) is considered evidence of endothelial dysfunction. Besides basal differences in responses to these two substances, LDF enables study of the oscillatory components in the blood flow (<xref rid="bib45 bib66 bib42 bib65" ref-type="bibr">Kvernmo et al., 1999; Stefanovska et al., 1999; Kvandal et al., 2003; Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>). Using LDF it was intended to examine, in particular, those blood flow frequencies that are known to reflect endothelial reactivity.</p>
      <p>The study was motivated by the perception of the cardiovascular system in terms of at least 5 distinct coupled oscillatory processes with different frequencies. The state of the system can be characterised by the oscillatory amplitudes, and by the couplings between the oscillators. Heart rate variability arises because lower frequency oscillations (especially, but not only, respiration) are coupled to the cardiac rhythm. Unlike many earlier studies, our interest therefore centres on blood flow <italic>dynamics</italic> (<xref rid="bib65" ref-type="bibr">Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>), rather than on basal values. The main advantage of this approach is that its frequency resolution enables the contributions from different physiological processes to be distinguished, and it has already been applied to other disease states related to the cardiovascular system: type 2 diabetes (<xref rid="bib71" ref-type="bibr">Urban&#x10D;i&#x10D;-Rovan et al., 2004</xref>) and post acute myocardial infarction (<xref rid="bib2" ref-type="bibr">A&#x17E;man-Juvan et al., 2008</xref>). It was postulated that the difference in endothelial reactivity of the CHF group and an age-matched healthy control (HC) group will be manifested in particular oscillatory components. The mechanism of action of &#x3B2;<sub>1</sub>-blockers in CHF is not fully understood, so the final aim of the study was to evaluate the effects that &#x3B2;<sub>1</sub>-blockers have on blood flow dynamics in CHF.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Subjects</title>
        <p>Patients for the CHF group were recruited either from cardiology clinics in the Royal Lancaster Infirmary or from patients referred directly for open access echocardiography. None of them exhibited significant edema. The severity of heart failure was established via echocardiography. Left ventricular diameter and left ventricular ejection fraction (LVEF) were determined. Inclusion criteria were that they had LVEF&#xA0;&lt;&#xA0;35% and symptoms between class II&#x2013;III of the New York Heart Association (NYHA) classification. Exclusion criteria were recent myocardial infarction, or cerebrovascular accident (within 6&#xA0;months), fibrillation, other life threatening co-morbidity, advanced frailty, current use of &#x3B2;-blocking drugs, or contra-indications to &#x3B2;-blocker therapy. All but one CHF patients remained on established treatment with angiotensin converting enzyme inhibitors and diuretics throughout the study; the exception was on an angiotensin-receptor antagonist and diuretics.</p>
        <p>After the initial set of measurements all CHF patients were then treated with Bisoprolol (a selective &#x3B2;<sub>1</sub>-antagonist). This was commenced in a dose of 1.25&#xA0;mg under direct observation, and then increased, at intervals of a minimum of 1&#xA0;week, through 2.5&#xA0;mg, 3.75&#xA0;mg and 5&#xA0;mg. Finally it was increased at intervals of a minimum of 4&#xA0;weeks from 7.5&#xA0;mg to 10&#xA0;mg. Upwards titration was stopped if symptomatic hypotension, or pulse rate&#xA0;&lt;&#xA0;50/min, or side-effects of the &#x3B2;-blocker, appeared. A second set of measurements was taken after 5&#xA0;weeks of a stable dose (&#x3B2;-CHF subject group) and 20&#xA0;&#xB1;&#xA0;10&#xA0;weeks after the first set of measurements. LVEF and NYHA were determined only before treatment. Patients' data are summarized in <xref rid="tbl1" ref-type="table">Table 1</xref>.</p>
        <p>Healthy age (66&#xA0;&#xB1;&#xA0;6&#xA0;years) and sex (8 F and 13 M) matched control subjects were recruited from the local community. None of them was on medication or had a history of cardiovascular disease or problems related to the cardiovascular system, including hypertension or hypercholesterolemia. A single set of measurements, identical to that recorded for CHF patients, was taken from each of them.</p>
        <p>All participants gave their informed consent in writing. The investigation conformed with the principles outlined in the Declaration of Helsinki and was approved by the Local Ethics Committee of the Morecambe Bay Hospitals Trust.</p>
      </sec>
      <sec>
        <title>Measurements</title>
        <p>Subjects lay supine on a bed and relaxed for 15&#xA0;min prior to the commencement of recording. Peripheral blood flow, heart rate, respiration, and skin temperature were simultaneously recorded for 30&#xA0;min, based respectively on laser Doppler flowmetry (LDF), a conventional 3-lead ECG, a Biopac respiratory effort transducer placed around the thorax, and Thermilinear temperature sensors (YSI Inc, Ohio, USA) placed on the arm and leg. The ECG, respiration and temperature signals were amplified using a specially designed signal conditioning unit (Cardiosignals, Jo&#x17E;ef Stefan Institute, Slovenia). Signals were digitized at 400&#xA0;Hz with 16-bit resolution by use of a National Instruments PCI-6035E A/D converter, and stored in a personal computer. The temperature of the room was maintained at 21&#xA0;&#xB1;&#xA0;2&#xA0;&#xB0;C.</p>
      </sec>
      <sec>
        <title>Laser Doppler flowmetry</title>
        <p>Skin blood flow signals were measured by the laser Doppler perfusion technique using a DRT4 LDF monitor (Moor Instruments Ltd, Axminster, UK). Two MPI&#x2013;V2 probes were mounted within MIC1&#x2013;IONlr chambers, where the vasoactive substances were inserted for iontophoretic administration in the same area as that where the blood flow was being recorded. Measurements were made on the volar aspect of the right forearm, choosing areas of skin that were free from blemishes. Both probes were positioned in areas with similar vasculature and without larger vessels in their vicinity. For each set of measurements the two chambers were placed 2&#xA0;cm apart with random relative orientation. Near-infra-red light (wavelength 780&#xA0;nm) was delivered to the probes via a nearly loss-free optical fibre. The back-scattered light was collected and returned to the monitor via another optical fibre, where it was converted to an analogue electrical signal. The cut-off frequency of the low-pass filter was 22.5&#xA0;kHz, and an output time constant of 0.1&#xA0;s was selected. The LDF probes were calibrated against a flux standard (Moor Instruments) and the blood flow was expressed in arbitrary units (AU).</p>
      </sec>
      <sec>
        <title>Iontophoresis</title>
        <p>Two vasodilators were iontophoretically applied: ACh whose action is endothelium-dependent, and SNP an endothelium-independent direct NO donor. The difference in the blood flow enhancements that they produce in any oscillatory component is related to the responsiveness of the vascular endothelium (<xref rid="bib45 bib66 bib42 bib65" ref-type="bibr">Kvernmo et al., 1999; Stefanovska et al., 1999; Kvandal et al., 2003; Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>). The 1% ACh and SNP solutions were prepared on the day of the study in each case. They were drawn through the cutaneous barrier at each of the LDF measuring sites by means of a constant electrical current of 100&#xA0;&#x3BC;A. A Moor Instruments MIC1-e current controller was used. The iontophoresis current was applied in 7 pulses of 20&#xA0;s, with a separation of 240&#xA0;s between each, as indicated in <xref rid="fig1" ref-type="fig">Fig. 1</xref>a. <xref rid="fig1" ref-type="fig">Fig. 1</xref>b,c shows examples of blood flow responses to ACh and SNP for a healthy subject. They illustrate the large increase of oscillatory activity that typically occurs in addition to the increased average flow.</p>
      </sec>
      <sec>
        <title>Data analysis</title>
        <p>The time averages of the signals from the LDF probes were calculated, and the signals were then resampled at 10&#xA0;Hz using a moving average technique. Trends were removed by giving the moving average a window length of 200&#xA0;s, thereby eliminating frequencies below 0.005&#xA0;Hz. Following this pre-processing, the wavelet transform (using the Morlet mother wavelet (<xref rid="bib55" ref-type="bibr">Morlet, 1983</xref>)) was computed to analyse the frequency content of the signals. The advantages in comparison to conventional Fourier techniques include the logarithmic frequency resolution, which enables an extremely wide range of frequencies to be accommodated: in the present case, the characteristic frequencies of oscillations in the LDF signals differed by a factor&#xA0;&gt;&#xA0;100. All data analyses including the wavelet transform and data presentation were performed using code written within Matlab (The MathWorks, Inc.).</p>
        <p>Computation of the wavelet transform of the blood flow signal yields the usual 3-dimensional structure above the time&#x2013;frequency plane, exhibiting clearly resolved spectral peaks whose positions vary in time (<xref rid="bib66 bib65" ref-type="bibr">Stefanovska et al., 1999; Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>) as shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>a, and a time-average as shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>b. The positions of the spectral peaks also differ slightly from subject to subject. In earlier work, based on 20-minute recordings, five frequency intervals were defined (<xref rid="bib66 bib65" ref-type="bibr">Stefanovska et al., 1999; Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>) such that each of them contains only one peak: 0.0095&#x2013;0.021, 0.021&#x2013;0.052, 0.052&#x2013;0.145, 0.145&#x2013;0.6, and 0.6&#x2013;1.6&#xA0;Hz. They are attributed respectively to NO-dependent endothelial (<xref rid="bib45 bib66 bib42 bib41 bib68" ref-type="bibr">Kvernmo et al., 1999; Stefanovska et al., 1999; Kvandal et al., 2003, 2006; Stewart et al., 2007</xref>), neurogenic (<xref rid="bib35 bib64 bib47" ref-type="bibr">Kastrup et al., 1989; S&#xF6;derstr&#xF6;m et al., 2003; Landsverk et al., 2006</xref>), myogenic (<xref rid="bib45 bib34 bib9" ref-type="bibr">Kvernmo et al., 1999; Johnson, 1991; Bertuglia et al., 1994</xref>), respiratory and cardiac processes, as summarized in <xref rid="tbl2" ref-type="table">Table 2</xref>. The lowest detectable frequency component depends on the length of the signal and therefore longer recordings enabled investigations of blood flow spectrum below 0.0095&#xA0;Hz. In the study of Kvandal et al. 30-minute LDF recordings were performed and an additional spectral peak centred near 0.007&#xA0;Hz was observed and defined as the sixth frequency subinterval 0.005&#x2013;0.0095&#xA0;Hz (<xref rid="bib41" ref-type="bibr">Kvandal et al., 2006</xref>). The physiological origin of this oscillation was investigated in the latter study and was shown to be related to endothelial activity, but not related to NO or prostaglandins. Therefore an endothelial regulatory process, different from that in the 0.0095&#x2013;0.021 frequency interval, has been suggested.</p>
        <p>These six spectral peaks have recently been confirmed in an independent study (<xref rid="bib26" ref-type="bibr">Hafner et al., 2007</xref>) based on wavelet transformation of LDF data from healthy subjects and are also investigated in the present study.</p>
        <p>For convenience, the frequency intervals are labeled I&#x2013;VI as specified in <xref rid="tbl2" ref-type="table">Table 2</xref> and indicated in <xref rid="fig2" ref-type="fig">Fig. 2</xref>b. Note that, compared to earlier work (<xref rid="bib65" ref-type="bibr">Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>), the intervals are redesignated, now numbering them starting from the high frequency end, in order to reflect the probable future discovery of oscillatory components at even lower frequencies. In addition, to allow for the increased heart rate in CHF patients, the 1.6&#xA0;Hz boundary value of the heartbeat-related frequency range (interval I) has been increased to 2&#xA0;Hz. Detailed description of all the oscillations and their physiological origin is presented in the <xref rid="app1" ref-type="sec">Appendix A</xref>.</p>
        <p>Two measures are used to quantify the contribution of the oscillations to the total blood flow: their absolute and normalised spectral amplitude. The word &#x2018;spectral&#x2019; indicates they are both calculated from the coefficients of the wavelet transform. Absolute spectral amplitude is the mean value of the wavelet transform, and was calculated separately within each frequency interval. Absolute spectral amplitude over the whole frequency range from 0.005 to 2&#xA0;Hz was also calculated. To differentiate it from absolute amplitudes within specific intervals, it was introduced as average spectral amplitude. The normalised spectral amplitudes are calculated from the absolute spectral amplitudes and are defined as the ratio between the absolute spectral amplitude within a given subinterval and the average spectral amplitude.</p>
        <p>R-peaks in ECG signals were automatically detected and manually checked, and the corresponding instantaneous heart rate (IHR) time series was generated, composed of inverse values of R&#x2013;R periods. The mean heart rate (HR) for each subject was then obtained as a time-average of the IHR signal and the heart rate variability was defined as its standard deviation. In addition, maximal values in the respiration signals were automatically detected, manually checked, and analysed in a similar manner to yield the instantaneous respiration frequency (IRF) time series. The mean respiratory frequency (RF) was obtained as a time-average of IRF and the respiratory frequency (RF) variability was introduced as the standard deviation of IRF.</p>
        <p>The analysis was blinded, in that the relevant researcher had no connection with the experiments, but simply analyzed the anonymized time-series data with which he was provided.</p>
      </sec>
      <sec id="sec1">
        <title>Statistical analysis and presentation</title>
        <p>A nonpaired, nonparametric, Wilcoxon rank sum test was used to obtain the probability that two group distributions were equal (data presented in <xref rid="fig4 fig5" ref-type="fig">Figs. 4 and 5</xref>). A paired, Wilcoxon signed rank test was used to obtain the probability that the effect of two substances, ACh and SNP, was equal for a given group (data presented in <xref rid="fig6" ref-type="fig">Fig. 6</xref>). For hemodynamic data (<xref rid="fig3" ref-type="fig">Fig. 3</xref>) and skin temperature parametric <italic>t</italic>-tests were used, a nonpaired one in comparing patients with controls and a paired one between patient groups. Paired and nonpaired Wilcoxon tests were used to produce the statistics in <xref rid="fig7" ref-type="fig">Fig. 7</xref>. A nonpaired test was used to compare HC with patients before and after treatment, while a paired test was used to compare both patient groups.</p>
        <p>In all hypothesis tests a value of <italic>p&#xA0;</italic>&lt;&#xA0;0.05 was considered significant. The graphical data in <xref rid="fig3" ref-type="fig">Fig. 3</xref> and those that follow below are presented in each case as a box with lines drawn at the 25th percentile, the median and the 75th percentile. Whiskers extend from the ends of the box to the most extreme data value within 1.5&#xA0;&#xD7;&#xA0;IQR (where IQR is the inter-quartile range of the box). The range 0.01&#xA0;&lt;&#xA0;<italic>p</italic>&#xA0;&lt;&#xA0;0.05 is indicated by &#x204E; and <italic>p</italic>&#xA0;&lt;&#xA0;0.01 by &#x204E;&#x204E;. The statistical analysis was performed using Matlab Statistics Toolbox (The MathWorks, Inc.).</p>
        <p>The demographic data in <xref rid="tbl1" ref-type="table">Table 1</xref> are displayed as mean&#xA0;&#xB1;&#xA0;SD.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Hemodynamic data</title>
        <p>Treatment with &#x3B2;<sub>1</sub>-blockers resulted in a significant reduction in both systolic and diastolic blood pressure. The systolic pressure decreased from 141&#xA0;&#xB1;&#xA0;16 to 124&#xA0;&#xB1;&#xA0;18&#xA0;mm Hg (<italic>p</italic>&#xA0;=&#xA0;0.003). The diastolic pressure decreased from 77&#xA0;&#xB1;&#xA0;12 to 62&#xA0;&#xB1;&#xA0;10&#xA0;mm Hg (<italic>p</italic>&#xA0;=&#xA0;0.002).</p>
        <p>The heart rate decreased significantly from 1.31&#xA0;&#xB1;&#xA0;0.27 to 0.95&#xA0;&#xB1;&#xA0;0.15&#xA0;Hz (<italic>p</italic>&#xA0;=&#xA0;0.0003). Although HR variability is not relevant to the main findings of this study, we noted that it decreased very slightly, mainly on account of less ectopy. For the group, the number of ectopic beats dropped from 4.1 to 1.2 per minute. With ectopics included, HR variability was significantly greater in the CHF group than in the HCs; when the analysis was repeated with the extra-systoles removed (as shown), there was no significant difference between HR variability in the HC and CHF groups.</p>
        <p>For the first time we have demonstrated that neither the RF nor RF variability were significantly changed by treatment. <xref rid="fig3" ref-type="fig">Fig. 3</xref> summarizes the heart and respiration statistics for all three subject groups, including the healthy controls. Note that, in the CHF group, HR, RF and RF variability are all significantly higher than for the age-matched HCs. Treatment had no statistically significant effect on either RF or RF variability.</p>
      </sec>
      <sec>
        <title>Skin temperature</title>
        <p>There was a small decrease in patients' skin temperature as a result of the &#x3B2;<sub>1</sub>-blocker treatment (on arms 35.09&#xA0;&#xB1;&#xA0;1.49&#xA0;&#xB0;C before, 34.19&#xA0;&#xB1;&#xA0;1.18&#xA0;&#xB0;C after). The change is smaller than the variation between individual patients and is statistically insignificant.</p>
      </sec>
      <sec>
        <title>CHF compared to HC</title>
        <p>Effect of ACh and SNP on mean value of the LDF signal and average spectral amplitude: a comparison of the HC and CHF groups' responses to ACh and SNP is presented in <xref rid="fig4" ref-type="fig">Fig. 4</xref>: (a) shows mean blood flow and (b) the average spectral amplitude. There are highly significant differences in the mean flows between these two subject groups, in their responses to both ACh and SNP. However, there are no statistically significant differences between them in the average spectral amplitudes of their responses to ACh and SNP.</p>
        <p>Effect of ACh and SNP on oscillatory flow components: <xref rid="fig5" ref-type="fig">Fig. 5</xref> presents data comparable to those of <xref rid="fig4" ref-type="fig">Fig. 4</xref>, but with added frequency discrimination, dividing the responses into the frequency intervals I&#x2013;VI defined above. It is evident that almost all the oscillatory components are affected by CHF, but the effect on the lowest two seems to be different for the two vasodilators.</p>
        <p>In more detail, there is a distinction between the CHF and HC groups in their absolute spectral amplitudes in interval VI, which is significant in response to ACh (<xref rid="fig5" ref-type="fig">Fig. 5</xref>a) but not to SNP (<xref rid="fig5" ref-type="fig">Fig. 5</xref>c). The same is true of their normalised spectral amplitudes (5b and d). Within intervals III and IV, there are highly significant differences between the CHF and HC groups (5a&#x2013;d), but no distinction between their responses to ACh (5a,b) and SNP (5c,d). There is a significant difference between the normalized amplitudes for the two groups in interval V for ACh (5b).</p>
      </sec>
      <sec>
        <title>Effect of &#x3B2;<sub>1</sub>-blockers</title>
        <p>The effect of Bisoprolol was evaluated in two different ways. First, the responses to ACh before and after the treatment were compared. Similarly, the comparison of responses to SNP before and after the treatment was performed. After treatment the response to ACh was slightly increased for each oscillatory component, but the increase was not statistically significant. The response to SNP did not change in any of the intervals.</p>
        <p>Secondly, the responses to ACh and SNP were compared. The comparison was performed before the treatment and after the treatment as well as for the HC group. A significant difference between the responses to the two substances was found only within the lowest two frequency intervals and this is shown in <xref rid="fig6" ref-type="fig">Fig. 6</xref>.</p>
        <p>The figure compares absolute and normalized spectral amplitudes in response to ACh and SNP for all three subject groups. Parts (a) and (d) illustrate the differences in response to ACh and SNP in the HC group. The difference in normalized amplitude in interval V has been demonstrated in several earlier studies (<xref rid="bib45 bib66 bib42 bib65 bib41" ref-type="bibr">Kvernmo et al., 1999; Stefanovska et al., 1999; Kvandal et al., 2003; Stefanovska and Bra&#x10D;i&#x10D;, 1999, Kvandal et al., 2006</xref>). Note that there is, as recently discussed (<xref rid="bib41" ref-type="bibr">Kvandal et al., 2006</xref>), a statistically significant difference also in interval VI.</p>
        <p>Parts (b) and (e) of <xref rid="fig6" ref-type="fig">Fig. 6</xref> illustrate the differences in response to ACh and SNP in the CHF group. There is no statistically significant difference in absolute (6b) and normalised spectral amplitude (6e) in the case of the CHF patients. Following treatment with &#x3B2;<sub>1</sub>-blockers, however, the CHF-&#x3B2; group exhibits differences in response to ACh and SNP in interval VI that are statistically significant, both in the absolute (6c) and in the normalised spectral amplitude (6f). The differences in response to ACh and SNP in interval V seen in the HC group are not, however, restored by the &#x3B2;<sub>1</sub>-blocker treatment.</p>
        <p><xref rid="fig7" ref-type="fig">Fig. 7</xref> compares the three subject groups, HC, CHF and CHF-&#x3B2; directly in terms of their responses to ACh and SNP in intervals V and VI. In response to ACh in interval VI, there is a significant difference between HC and CHF but not between HC and CHF-&#x3B2; (<xref rid="fig7" ref-type="fig">Fig. 7</xref>a). In response to SNP there is a significant difference between HC and CHF-&#x3B2; in interval VI (<xref rid="fig7" ref-type="fig">Fig. 7</xref>b). No statistically significant difference between any of the three groups was observed in interval V, neither with ACh (<xref rid="fig7" ref-type="fig">Fig. 7</xref>a) nor with SNP (<xref rid="fig7" ref-type="fig">Fig. 7</xref>b).</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The major findings in this study are that patients with CHF have significant abnormalities in endothelial function compared with healthy controls, and that treatment with Bisoprolol, a selective &#x3B2;<sub>1</sub> antagonist, partially reverses the endothelial dysfunction that is found in patients with CHF. Whilst the mechanisms for the improvement in endothelial function are not explored in the present study the differences between intervals V and VI help to shed some light on the complex effects seen at the level of endothelial regulation. The changes in CHF as compared to healthy controls, and the effect of &#x3B2;<sub>1</sub>-blockers on endothelial function in CHF patients, are now discussed.</p>
      <sec>
        <title>Endothelial dependent oscillatory components</title>
        <p>The fact that the oscillatory amplitudes in intervals V and VI are differentially affected by ACh and SNP demonstrates that activity in both intervals is associated with the endothelium. This finding was first reported in the work by <xref rid="bib41" ref-type="bibr">Kvandal et al., 2006</xref>, and has been confirmed in the present study. Moreover, we have demonstrated that both intervals are abnormal in CHF as compared with healthy controls. Indeed, impaired endothelium-dependent vasodilatation and increased plasma concentration of a variety of neurohormones e.g. endothelin, angiotensin II, and natriuretic peptides in CHF, have been previously described (<xref rid="bib73" ref-type="bibr">Vanhoutte, 1996</xref>). In addition, increased production of NO has been reported as an effect of &#x3B2;-blockers (<xref rid="bib32" ref-type="bibr">Ignarro, 2004</xref>).</p>
        <p>The reason for using iontophoresis for our administration of ACh and SNP was twofold. First, a comparison of responses to endothelium-dependent and endothelium-independent vasodilation provides a measure of endothelial activity. Secondly, vasodilator substances will, by mechanism of their action increase the mean value of the flow as well as all the oscillatory components. This is especially important in facilitating measurements of the low frequency oscillations which make a relatively low contribution to the flow in terms of energy.</p>
        <p>Detailed information about the oscillations in these two intervals and their origin can be found in the <xref rid="app1" ref-type="sec">Appendix A</xref>.</p>
      </sec>
      <sec>
        <title>CHF patients compared to healthy controls</title>
        <p>The results in <xref rid="fig5" ref-type="fig">Fig. 5</xref> clearly demonstrate that the responsiveness of the vascular endothelium in CHF patients is reduced compared to healthy controls. This finding has been well described in previous studies (<xref rid="bib18 bib54" ref-type="bibr">Drexler et al., 1992; Morgan et al., 2004</xref>) of CHF patients. However, in those studies, invasive measurement techniques were used and/or the results were based on mean values of vascular responses, without the frequency discrimination. The current study, based on studying oscillations in addition to mean flows, has derived similar but more extensive information using entirely noninvasive techniques. Abnormalities of endothelial function in CHF are almost certainly multifactorial. Previous work has implicated NO through either decreased production (<xref rid="bib8" ref-type="bibr">Bernstein et al., 1997</xref>), increased degradation of NO or decreased NO bioavailability (<xref rid="bib6" ref-type="bibr">Belch et al., 1991</xref>). The expression of endothelial NO synthase (eNOS) has been shown to be reduced in both rats (<xref rid="bib14" ref-type="bibr">Comini et al., 1996</xref>) and dogs (<xref rid="bib63" ref-type="bibr">Smith et al., 1996</xref>) with experimental heart failure.</p>
      </sec>
      <sec>
        <title>CHF post &#x3B2;<sub>1</sub>-blockade</title>
        <p>The differing responses of the CHF and CHF-&#x3B2; groups (<xref rid="fig6" ref-type="fig">Fig. 6</xref>) found in the present study show clear evidence that treatment with Bisoprolol brings an increase in endothelial responsiveness in frequency interval VI: the ACh/SNP differentiation in absolute and normalized spectral amplitude for untreated CHF patients is statistically insignificant (6b and 6e), whereas for the CHF-&#x3B2; group it is statistically significant (6c and 6f). Treatment with Bisoprolol evidently ameliorates the impairment of endothelial responsiveness associated with CHF.</p>
        <p>In detail, the lack of ACh/SNP differentiation for CHF in interval VI can be explained by the fact that the response to ACh is significantly decreased in CHF compared to HC (<xref rid="fig7" ref-type="fig">Fig. 7</xref>a) while the SNP response is not (<xref rid="fig7" ref-type="fig">Fig. 7</xref>b). After treatment the ACh response increases compared to CHF (<xref rid="fig7" ref-type="fig">Fig. 7</xref>a), although not significantly. On the other hand the response to SNP is slightly reduced (<xref rid="fig7" ref-type="fig">Fig. 7</xref>b).</p>
        <p>The mechanism of action of &#x3B2;<sub>1</sub>-blockers in CHF is still not wholly understood. Likely mechanisms involve reduction in sympathetic tone, increase in vagal tone, reduction of subendocardial ischaemia, reduction in rennin and endothelin release, increasing norepinephrine re-uptake, and reducing inflammatory cytokines (<xref rid="bib62" ref-type="bibr">Silke, 2006</xref>). It has been reported in several studies that ventricular function, measured by left ventricular ejection fraction (LVEF), improves as a result of &#x3B2;-blocker treatment in CHF (<xref rid="bib72" ref-type="bibr">Van Campen et al., 1998</xref>). Whether the increased LVEF might have an indirect effect on our findings is not known and further work will have to be done.</p>
        <p>We note that &#x3B2;<sub>1</sub>-blockers operate in many different ways, and it has yet to be determined which of them is/are responsible for the observed changes in low frequency blood flow spectra.</p>
        <p>What the present study has shown is that CHF patients exhibit blood flow abnormalities in frequency interval VI, that iontophoresis and wavelet analysis enable this abnormality to be detected, and that the medication partially restores normal function.</p>
      </sec>
      <sec>
        <title>Study limitations</title>
        <p>As with all clinical studies involving patient follow up over time, it was not feasible to accommodate for the effects of disease progression. In addition all patients were on medication at the commencement of the study, and alteration of doses of other drugs e.g. diuretics was sometimes necessary at the discretion of the prescribing physician.</p>
        <p>The study was not performed in a placebo-controlled fashion because it would have been ethically unacceptable to withhold a life-prolonging treatment from 50% of the patients for 12&#xA0;weeks.</p>
        <p>The main reason for the introduction of normalised spectral amplitudes is to reduce the inter-subject variability seen in the case of absolute amplitudes. However, an effect on normalised amplitude within a specific interval can then result from changes in the rest of the spectrum, not only from changes in the interval under consideration. For this reason special care should be taken when interpreting normalised data. In the present study, the main findings are based on comparison of responses to ACh and SNP within frequency intervals V and VI (<xref rid="fig6" ref-type="fig">Fig. 6</xref>). Average spectral amplitudes for both substances did not differ between any of the subject groups and differences between the effects of the substances were found only in the two lowest frequency intervals. This suggests that oscillations at higher frequencies, such as those related to heartbeat and respiration did not alter the normalised spectral amplitudes at low frequencies.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>The main conclusion is that, compared to healthy controls, CHF patients exhibit abnormally attenuated blood flow oscillations in frequency intervals V and VI, which represent different aspects of endothelial function. Treatment with Bisoprolol shifts the abnormality in spectral amplitude back towards the findings in healthy controls.</p>
        <p>In more detail, iontophoretic administration of the endothelium-dependent and endothelium-independent vasodilators ACh and SNP has confirmed that the low-frequency spectral peaks in intervals V and VI of the LDF blood flow signal are associated with endothelial reactivity. Both peaks are significantly attenuated in patients with CHF. These spectral peaks are respectively governed by NO, and an as yet unknown factor. Treatment of CHF patients with the &#x3B2;<sub>1</sub>-blocker Bisoprolol moves the spectral amplitude of interval VI closer to that of the healthy controls. However, given that no significant change of activity in interval V is detected as a result of the treatment, whereas a highly significant change is observed in interval VI, it can be inferred that the effects of Bisoprolol on the endothelium are at least partly mediated through a non-NO mechanism.</p>
      </sec>
    </sec>
    <sec id="app1">
      <label>Appendix A</label>
      <title>Oscillations in the LDF time series and their physiological origin</title>
      <p>The dynamics of the microcirculatory flow, measured by LDF, consists of rhythmic variations. It can therefore be analysed using spectral techniques. The strengths of individual oscillating components, revealed by the spectrum, provide information about the dynamics of vascular regulatory mechanisms.</p>
      <p>In earlier work, wavelet analysis of 20-minute LDF recordings using the Morlet mother wavelet resolved five oscillations in the time-frequency domain, the lowest one around 0.01&#xA0;Hz (<xref rid="bib11" ref-type="bibr">Bra&#x10D;i&#x10D; and Stefanovska, 1998</xref>). By tracing the characteristic frequencies of oscillations in time, the spectrum was divided into five intervals, such that only one oscillation was present in each interval (<xref rid="bib11 bib66 bib65" ref-type="bibr">Bra&#x10D;i&#x10D; and Stefanovska, 1998; Stefanovska et al., 1999; Stefanovska and Bra&#x10D;i&#x10D;, 1999</xref>). Longer recordings enabled investigations of even lower frequency components in LDF signals and from 30-minute recordings another spectral component was observed at frequency around 0.007&#xA0;Hz (<xref rid="bib41" ref-type="bibr">Kvandal et al., 2006</xref>). It was shown not to be an artefact related to the measurement or to signal processing technique.</p>
      <p>The positions of the characteristic frequencies vary slightly, with time and between subjects. They are also changed during physical activity, and are modified in some diseases. An ideal division of the spectrum into frequency intervals is therefore impossible. However, specific physiological processes appear to dominate in specific frequency intervals, and wavelet-based analysis provides a promising way of identifying them, especially for low frequency oscillations. Several recent studies have independently confirmed the presence of the oscillations in LDF recordings (<xref rid="bib23 bib31 bib49 bib58 bib48 bib68 bib26" ref-type="bibr">Geyer et al., 2004; Humeau et al., 2004; Liu et al., 2006; Rossi et al., 2006; Li et al., 2006; Stewart et al., 2007; Hafner et al., 2007</xref>) and investigated their physiological origin. However, further work is necessary to fully understand the complex mechanisms involved in the regulation of the microvascular blood flow.</p>
      <p>These mechanisms were recently reviewed by <xref rid="bib61" ref-type="bibr">Segal (2005)</xref> who writes &#x201C;With vasomotor tone reflecting myogenic contraction of smooth muscle cells modulated by shear stress on the endothelium, the initiation of functional vasodilation and its modulation by sympathetic innervation dictate how and where blood flow is distributed in response to metabolic demand&#x201D;. Although metabolic demand can be strongly enhanced by exercise, it is of course continuously present in a living system. Moreover, the oscillatory nature of the flow generated by rhythmic activity of the heart can be expected to be associated with oscillatory mechanisms of regulation. Each of the regulatory mechanisms manifests within a particular frequency interval. In what follows we list the six previously defined (<xref rid="bib41" ref-type="bibr">Kvandal et al., 2006</xref>) frequency intervals and we summarise the rationale of associating them with specific physiological processes.</p>
      <sec>
        <title>Frequency interval I (0.6&#x2013;2&#xA0;Hz), related to the heartbeat and frequency interval II (0.145&#x2013;0.6&#xA0;Hz), related to the respiratory activity</title>
        <p>The oscillation with the highest frequency, around 1&#xA0;Hz, is related to the activity of the heart. The respiratory activity is around 0.25&#xA0;Hz. Both oscillatory components appear in the spectrum of the LDF signal and their physiological origin can easily be demonstrated by comparing the frequency content of ECG, respiration and blood pressure signals with that of a simultaneously measured LDF blood flow signal.</p>
      </sec>
      <sec>
        <title>Frequency interval III (0.052&#x2013;0.145&#xA0;Hz), related to intrinsic myogenic activity</title>
        <p>In 1964 Folkow suggested that oscillatory changes of arteriolar diameter are resulted from myogenic control <xref rid="bib21" ref-type="bibr">(Folkow, 1964)</xref>. Several years later, <xref rid="bib34" ref-type="bibr">Johnson (1991)</xref> showed that blood vessels respond to transmural pressure elevation with constriction, and to pressure reduction with dilation. He termed this behaviour myogenic response and suggested that it is inherent to smooth muscle and independent of neural, metabolic, and hormonal influences. It was shown that this response is not constant for all the vessels and that a longitudinal gradient in myogenic responsiveness exists within an arteriolar network (<xref rid="bib16" ref-type="bibr">Davis, 1993</xref>).</p>
        <p>Spontaneous activity recorded in microvascular smooth muscle cells was shown to lie in the range 4&#x2013;10 events a minute (0.07&#x2013;0.1&#xA0;Hz) (<xref rid="bib24" ref-type="bibr">Golenhofen, 1970</xref>). Several studies suggested that these waves are of local origin representing intrinsic myogenic activity of smooth muscle cells in resistance vessels (<xref rid="bib59 bib13 bib52 bib33 bib35 bib29 bib10" ref-type="bibr">Salerud et al., 1983; Colantuoni et al., 1984; Meyer et al., 1988; Intaglietta, 1989; Kastrup et al., 1989; Hoffmann et al., 1990; Bollinger et al., 1991</xref>). Rhythmical variation in the same frequency interval (6 to 10 cycles a minute) had been observed in blood pressure recordings by <xref rid="bib69" ref-type="bibr">Traube (1865)</xref> and was confirmed by <xref rid="bib28" ref-type="bibr">Hering (1869)</xref>. In 1876 Siegmund Mayer observed similar oscillations (<xref rid="bib51" ref-type="bibr">Mayer, 1876</xref>). <xref rid="bib38" ref-type="bibr">Killip (1962)</xref> presented evidence that Mayer waves are accompanied by rhythmic fluctuations in vascular resistance.</p>
        <p>In a recent study on small arteries in rats, it was shown that blockade of adrenoceptors, which mediate the effect of the main transmitter in these vessels, does not alter the myogenic response (<xref rid="bib1" ref-type="bibr">Anschutz and Schubert, 2005</xref>). Similar findings have been reported after inhibition of nerve action potentials by tetrodotoxin, after blockade of postsynaptic receptor function by receptor antagonists and after chemical vessel denervation in cat cerebral (<xref rid="bib27" ref-type="bibr">Harder, 1984</xref>), rat cerebral (<xref rid="bib57" ref-type="bibr">Osol and Halpern, 1985</xref>), and rat saphenous (Berczi et al., <xref rid="bib7" ref-type="bibr">1992</xref>) arteries. These studies provide supporting evidence that the myogenic response is due to an action of transmural pressure on smooth muscle cells only. This is in agreement with the study in humans, where blood flow oscillations from free microvascular flaps deprived of sympathetic nerve activity (SNA) and from intact skin were compared (<xref rid="bib64" ref-type="bibr">S&#xF6;derstr&#xF6;m et al., 2003</xref>). It was shown that the SNA was not manifested in the frequency interval above 0.05&#xA0;Hz.</p>
        <p>Wavelet analysis of LDF signals was used to trace the myogenic activity related oscillation in time and attribute it to a specific frequency interval. The technique was not used to investigate the physiological origin of this oscillation, which had already been revealed from both blood flow and blood pressure signals, as described above.</p>
        <p>The application of wavelet analysis to blood flow signals has revealed that the amplitude of myogenic oscillations is increased by exercise (<xref rid="bib43 bib30" ref-type="bibr">Kvernmo et al., 1998; Hubscher et al., 2006</xref>) and decreased by local cooling (<xref rid="bib4 bib5" ref-type="bibr">Bandrivskyy et al., 2004b</xref>).</p>
      </sec>
      <sec>
        <title>Frequency interval IV (0.021&#x2013;0.052&#xA0;Hz), related to neurogenic (sympathetic) activity</title>
        <p>An oscillation with a characteristic frequency around 0.04&#xA0;Hz has been observed in blood pressure, blood flow and HRV signals. It was attributed either to metabolic (<xref rid="bib39" ref-type="bibr">Kitney et al., 1985</xref>) or to neurogenic activity (<xref rid="bib67" ref-type="bibr">Stefanovska et al., 1997</xref>), which is superimposed on myogenic activity in the regulation of the blood pressure through adjustment of the vessel's radius.</p>
        <p><xref rid="bib35" ref-type="bibr">Kastrup et al. (1989)</xref> termed these rhythmic variations &#x3B2;-oscillations and, in agreement with the study of <xref rid="bib25" ref-type="bibr">Golenhofen and Hildebrandt (1958)</xref>, showed that in humans they disappear after local and ganglionic nerve blockade and in chronically sympathectomized tissue. They suggested that &#x3B2;-oscillations are a vascular reaction of purely neurogenic origin. Similarly, in an LDF study of oscillations in rabbit skeletal muscle tissue, slow waves with a frequency of around 1&#x2013;3 per minute were suggested to be under neurogenic control since they disappeared after pharmacological nerve blockade (<xref rid="bib60" ref-type="bibr">Schmidt et al., 1992</xref>).</p>
        <p>Using wavelet analysis with a logarithmic frequency resolution (<xref rid="bib66" ref-type="bibr">Stefanovska et al., 1999</xref>) several studies confirmed the involvement of sympathetic nerve activity in this low frequency interval. Analysis of skin blood flows on rats' paws has shown a significant decrease in the relative energy contribution to blood flow oscillations in the low frequency spectrum only in denervated paws (<xref rid="bib3" ref-type="bibr">Bajrovi&#x107; et al., 2000</xref>). In humans, LDF signals from the surfaces of free microvascular flaps, deprived of sympathetic nerve activity, showed reduced spectral amplitude compared to adjacent intact skin only in the 0.02&#x2013;0.05&#xA0;Hz low frequency interval (<xref rid="bib64" ref-type="bibr">S&#xF6;derstr&#xF6;m et al., 2003</xref>). Two recently published studies have shown the 0.021&#x2013;0.052&#xA0;Hz frequency interval to be related to sympathetic activity: after brachial plexus block, a significant decrease was shown in the lower forearm skin compared to controls (<xref rid="bib47" ref-type="bibr">Landsverk et al., 2006</xref>), a result that was confirmed on a similar location as an effect of general anaesthesia (<xref rid="bib46" ref-type="bibr">Landsverk et al., 2007</xref>).</p>
        <p>An independent study has confirmed these findings in the same frequency interval by simultaneous measurements of LDF signals on the surfaces of a free latissimus dorsi myocutaneous flap and on the adjacent intact skin of a healthy limb (<xref rid="bib49" ref-type="bibr">Liu et al., 2006</xref>).</p>
      </sec>
      <sec>
        <title>Frequency interval V (0.0095&#x2013;0.021&#xA0;Hz), related to endothelial activity (partly NO-dependent)</title>
        <p>It is well accepted that ACh induces vasodilatation through enhancement of the activity of endothelial cells, but the exact mechanism and the mediators involved are still not fully understood. The involvement of endothelium in ACh-induced vasodilatation is the main difference as compared to vasodilatation by SNP. Therefore, iontophoresis with these two substances has been used to examine skin microvascular endothelial cell function (<xref rid="bib75 bib20 bib56" ref-type="bibr">Westerman et al., 1988; Enerothgrimfors et al., 1993; Morris and Shore, 1996</xref>). It was suggested (<xref rid="bib53" ref-type="bibr">Moncada et al., 1991</xref>) that impaired ACh-induced vasodilatation, as compared to the vasodilatation induced by SNP, could be taken as a demonstration of endothelial dysfunction.</p>
        <p>Following reports of endothelial and NO involvement in rhythmic activities, the hypothesis was tested that not only the mean value of the blood flow, but also its dynamics is modulated by endothelium (<xref rid="bib45" ref-type="bibr">Kvernmo et al., 1999</xref>). Using wavelet analysis of 20-minute LDF recordings with logarithmic frequency resolution, the difference between ACh and SNP responses was found to manifest in only one frequency interval, around 0.01&#xA0;Hz. The oscillation in this interval has been attributed to endothelium-mediated vasodilatation but its physiological origin has not been investigated. These findings were confirmed in a separate study on athletes and healthy control subjects using the same dose&#x2013;response protocol (<xref rid="bib44" ref-type="bibr">Kvernmo et al., 2003</xref>).</p>
        <p>Observation of an oscillatory component in the spectrum at an even lower frequency, around 0.007&#xA0;Hz, has led to 30-minute recordings of LDF signals and an iontophoresis protocol consisting of 7 equal pulses. The protocol was carefully chosen to avoid current induced vasodilation (iontophoretic currents less than 200&#xA0;&#x3BC;A and total charge less than 8&#xA0;mC) (<xref rid="bib75" ref-type="bibr">Westerman et al., 1988</xref>). Possible effects of the iontophoresis current (<xref rid="bib74" ref-type="bibr">Veber et al., 2004</xref>) and transdermal potential difference (<xref rid="bib4 bib5" ref-type="bibr">Bandrivskyy et al., 2004a</xref>) on the blood flow responses were investigated and were shown not to be involved in the low frequency oscillations.</p>
        <p>In further investigation of the low frequency oscillations, several other studies have confirmed the role of endothelium in frequency interval V (<xref rid="bib42 bib41 bib47 bib46" ref-type="bibr">Kvandal et al., 2003, 2006; Landsverk et al., 2006, 2007</xref>) including the present study on CHF. It was suggested that oscillations in this interval were partly mediated by NO, as they were reduced by infusion of <sc>l</sc>-NMMA and restored by <sc>l</sc>-arginine, but were not mediated by endogenous prostaglandins (Kvandal et al., <xref rid="bib42" ref-type="bibr">2003</xref>). The finding that oscillations within this frequency interval are NO-dependent was confirmed in a recent independent study (<xref rid="bib68" ref-type="bibr">Stewart et al., 2007</xref>).</p>
        <p>Oscillations in interval V were significantly reduced following both brachial plexus block (<xref rid="bib47" ref-type="bibr">Landsverk et al., 2006</xref>) and general anaesthesia (<xref rid="bib46" ref-type="bibr">Landsverk et al., 2007</xref>). Although the difference in responses to ACh and SNP in this interval was abolished after plexus block (<xref rid="bib47" ref-type="bibr">Landsverk et al., 2006</xref>), this was not the case following general anaesthesia (<xref rid="bib46" ref-type="bibr">Landsverk et al., 2007</xref>). The possible reason for this finding is that smooth muscle cell activity is reduced under general, but not under local, anaesthesia.</p>
      </sec>
      <sec>
        <title>Frequency interval VI (0.005&#x2013;0.0095&#xA0;Hz), related to endothelial activity (non-NO-dependent)</title>
        <p>As within frequency interval V, the proportion of the flow in frequency interval VI was shown to be significantly higher in response to ACh compared to SNP, indicating an endothelium related origin of the oscillation (<xref rid="bib41" ref-type="bibr">Kvandal et al., 2006</xref>). However, blocking the endothelial production of NO and prostaglandins did not affect this oscillation, suggesting possible involvement of other endothelial mechanisms.</p>
        <p>The possible involvement of endothelium in this frequency interval has also been demonstrated and discussed above in the present CHF study.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The research was supported by the Wellcome Trust (UK) and in part by the Slovenian Research Agency (Slovenia), the Engineering and Physical Sciences Research Council (UK), and the Medical Research Council (UK). The assistance of Alexander Balanov, Natalia Janson, Mark Lippett, and Yuri Shiogai in making the measurements, and help from Tracey Nuttall in relation to patient data, are gratefully acknowledged.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>Anschutz and Schubert, 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anschutz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of the myogenic response by neurogenic influences in rat small arteries</article-title>
          <source>Br. J. Pharmacol.</source>
          <year>2005</year>
          <volume>146</volume>
          <issue>2</issue>
          <fpage>226</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">16025142</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>A&#x17E;man-Juvan et al., 2008</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A&#x17E;man-Juvan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Urban&#x10D;i&#x10D;-Rovan</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>&#x160;tajer</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Skin blood flow and its oscillatory components in patients with acute myocardial infarction</article-title>
          <source>J. Vasc. Res.</source>
          <year>2008</year>
          <volume>45</volume>
          <issue>2</issue>
          <fpage>164</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">17962720</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>Bajrovi&#x107; et al., 2000</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bajrovi&#x107;</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>&#x10C;en&#x10D;ur</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ho&#x17E;i&#x10D;</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ribari&#x10D;</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The contribution of lumbar sympathetic neurones activity to rat's skin blood flow oscillations. Pflugers</article-title>
          <source>Arch.</source>
          <year>2000</year>
          <volume>439</volume>
          <issue>3</issue>
          <fpage>R158</fpage>
          <lpage>R160</lpage>
          <comment>Suppl S</comment>
        </citation>
      </ref>
      <ref id="bib4">
        <label>Bandrivskyy et al., 2004a</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bandrivskyy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>McClintock</surname>
              <given-names>P.V.E.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Role of transdermal potential difference during iontophoretic drug delivery</article-title>
          <source>IEEE Trans. Biomed. Eng.</source>
          <year>2004</year>
          <volume>51</volume>
          <issue>9</issue>
          <fpage>1683</fpage>
          <lpage>1685</lpage>
          <pub-id pub-id-type="pmid">15376518</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>Bandrivskyy et al., 2004b</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bandrivskyy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>McClintock</surname>
              <given-names>P.V.E.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Wavelet phase coherence analysis: application to skin temperature and blood flow</article-title>
          <source>Cardiovasc. Eng.</source>
          <year>2004</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>89</fpage>
          <lpage>93</lpage>
        </citation>
      </ref>
      <ref id="bib6">
        <label>Belch et al., 1991</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belch</surname>
              <given-names>J.J.F.</given-names>
            </name>
            <name>
              <surname>Bridges</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Chopra</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen free radicals and congestive heart failure</article-title>
          <source>Br. Heart. J.</source>
          <year>1991</year>
          <volume>65</volume>
          <fpage>245</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">2039668</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>Berczi et al., 1992</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berczi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Stekiel</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Contney</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Rusch</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Pressure-induced activation of membrane K+ current in rat saphenous artery hypertension</article-title>
          <source>Hypertension</source>
          <year>1992</year>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>725</fpage>
          <lpage>729</lpage>
          <comment>Part 2</comment>
          <pub-id pub-id-type="pmid">1592474</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>Bernstein et al., 1997</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernstein</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.P.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Forfia</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tuzman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hintze</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs</article-title>
          <source>Nitric Oxide</source>
          <year>1997</year>
          <volume>1</volume>
          <fpage>386</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="pmid">9441909</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>Bertuglia et al., 1994</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertuglia</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Colantuoni</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Intaglietta</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Effects of L-NMMA and indomethacin on arteriolar vasomotion in skeletal-muscle microcirculation of conscious and anesthetized hamsters</article-title>
          <source>Microvasc. Res.</source>
          <year>1994</year>
          <volume>48</volume>
          <fpage>68</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">7990724</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>Bollinger et al., 1991</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bollinger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Franzeck</surname>
              <given-names>U.K.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of flux motion in man by the laser doppler technique</article-title>
          <source>Blood Vessels</source>
          <year>1991</year>
          <volume>28</volume>
          <fpage>21</fpage>
          <lpage>26</lpage>
          <comment>Suppl. 1</comment>
          <pub-id pub-id-type="pmid">1834254</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>Bra&#x10D;i&#x10D; and Stefanovska, 1998</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bra&#x10D;i&#x10D;</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Wavelet-based analysis of human blood-flow dynamics</article-title>
          <source>Bull. Math. Biol.</source>
          <year>1998</year>
          <volume>60</volume>
          <issue>5</issue>
          <fpage>919</fpage>
          <lpage>935</lpage>
          <pub-id pub-id-type="pmid">9739620</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>Bristow, 2000</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bristow</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>b&#x2013;adrenergic receptor blockade in chronic heart failure</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>558</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="pmid">10662755</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>Colantuoni et al., 1984</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colantuoni</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bertuglia</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Intaglietta</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Quantitation of rhythmic diameter changes in arterial microcirculation</article-title>
          <source>Am. J. Physiol.</source>
          <year>1984</year>
          <volume>246</volume>
          <issue>4</issue>
          <fpage>H508</fpage>
          <lpage>H517</lpage>
          <pub-id pub-id-type="pmid">6720909</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>Comini et al., 1996</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Comini</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bachetti</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gaia</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pasini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Agnoletti</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pepi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ceconi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Curello</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Aorta and skeletal muscle NO synthase expression in experimental heart failure</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>1996</year>
          <volume>28</volume>
          <fpage>2241</fpage>
          <lpage>2248</lpage>
          <pub-id pub-id-type="pmid">8938577</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>Cracowski et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cracowski</surname>
              <given-names>J.-L.</given-names>
            </name>
            <name>
              <surname>Minson</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Salvat-Melis</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Halliwill</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Methodological issues in the assessment of skin microvascular function in humans</article-title>
          <source>Trends Pharmacol. Sci.</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>503</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">16876881</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>Davis, 1993</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Myogenic response gradient in an arteriolar network</article-title>
          <source>Am. J. Physiol.</source>
          <year>1993</year>
          <volume>264</volume>
          <issue>6</issue>
          <fpage>H2168</fpage>
          <lpage>H2179</lpage>
          <comment>Part 2</comment>
          <pub-id pub-id-type="pmid">8322948</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>Drexler, 1998</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drexler</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Hypertension, heart failure and endothelial function</article-title>
          <source>Am. J. Cardiol.</source>
          <year>1998</year>
          <volume>82</volume>
          <fpage>20S</fpage>
          <lpage>22S</lpage>
          <pub-id pub-id-type="pmid">9860351</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>Drexler et al., 1992</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drexler</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hayoz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>M&#xFC;nzel</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hornig</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Just</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>H.R.</given-names>
            </name>
            <name>
              <surname>Zelis</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Endothelial function in chronic congestive heart failure</article-title>
          <source>Am. J. Cardiol.</source>
          <year>1992</year>
          <volume>69</volume>
          <fpage>1596</fpage>
          <lpage>1601</lpage>
          <pub-id pub-id-type="pmid">1598876</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>Eichhorn and Bristow, 1996</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eichhorn</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Bristow</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Medical therapy can improve the biological properties of the chronically failing heart&#x2014;a new era in the treatment of heart failure</article-title>
          <source>Circulation</source>
          <year>1996</year>
          <volume>94</volume>
          <fpage>2285</fpage>
          <lpage>2296</lpage>
          <pub-id pub-id-type="pmid">8901684</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>Enerothgrimfors et al., 1993</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enerothgrimfors</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lindblad</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Westgren</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ihrmansandahl</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bevegard</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Noninvasive test of microvascular endothelial function in normal and hypertensive pregnancies</article-title>
          <source>Br. J. Obstet. Gynaecol.</source>
          <year>1993</year>
          <volume>100</volume>
          <issue>5</issue>
          <fpage>469</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="pmid">8518249</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>Folkow, ND</label>
        <citation citation-type="other">Folkow, B., 1964. Description of myogenic hypothesis. Circ. Res. 15(2S1), 279&#x2013;&amp;.</citation>
      </ref>
      <ref id="bib22">
        <label>Garlichs et al., 1999</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garlichs</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>M&#xFC;gge</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>W.G.</given-names>
            </name>
          </person-group>
          <article-title>Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells</article-title>
          <source>Eur. J. Clin. Invest.</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>12</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">10092983</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>Geyer et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geyer</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Brienza</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Boninger</surname>
              <given-names>M.L.</given-names>
            </name>
          </person-group>
          <article-title>Using wavelet analysis to characterize the thermoregulatory mechanisms of sacral skin blood flow</article-title>
          <source>J. Rehabil. Res. Dev.</source>
          <year>2004</year>
          <volume>41</volume>
          <issue>6A</issue>
          <fpage>797</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="pmid">15685468</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>Golenhofen, 1970</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Golenhofen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Slow rhythms in smooth muscle</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Buhlbring</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Brading</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Tomita</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <source>Smooth Muscle</source>
          <year>1970</year>
          <publisher-name>Edward Arnold Ltd</publisher-name>
          <publisher-loc>London</publisher-loc>
          <fpage>316</fpage>
          <lpage>342</lpage>
        </citation>
      </ref>
      <ref id="bib25">
        <label>Golenhofen and Hildebrandt, 1958</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golenhofen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hildebrandt</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Die beziehungen des blutdruckrhythmus zu atmung und peripherer durchblutung</article-title>
          <source>Pflugers Archiv fur die Gesamte Physiologie des Menschen und Tiere</source>
          <year>1958</year>
          <volume>267</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">13601010</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>Hafner et al., 2007</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hafner</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Brauer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Eichner</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Heinle</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rocken</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Strolin</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Wavelet analysis of skin perfusion in healthy volunteers</article-title>
          <source>Microcirculation</source>
          <year>2007</year>
          <volume>14</volume>
          <issue>2</issue>
          <fpage>137</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">17365668</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>Harder, 1984</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harder</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>Pressure-dependent membrane depolarization in cat middle cerebral-artery</article-title>
          <source>Circ. Res.</source>
          <year>1984</year>
          <volume>55</volume>
          <issue>2</issue>
          <fpage>197</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">6744529</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>Hering, 1869</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hering</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Ueber den Einfluss der Athmung auf den Kreislauf</article-title>
          <source>S.-B. Akad. Wiss. Wien, math.-nat. Kl.</source>
          <year>1869</year>
          <volume>60</volume>
          <fpage>829</fpage>
        </citation>
      </ref>
      <ref id="bib29">
        <label>Hoffmann et al., 1990</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffmann</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Yanar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Franzeck</surname>
              <given-names>U.K.</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Bollinger</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The frequency histogram &#x2014; a new method for the evaluation of laser doppler flux motion</article-title>
          <source>Microvas. Res.</source>
          <year>1990</year>
          <volume>40</volume>
          <issue>3</issue>
          <fpage>293</fpage>
          <lpage>301</lpage>
        </citation>
      </ref>
      <ref id="bib30">
        <label>Hubscher et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hubscher</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Vogt</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Banzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Assessment of exercise-induced changes of the microcirculation by wavelet transformation</article-title>
          <source>Deutsche Zeitschrift Fur Sportmedizin</source>
          <year>2006</year>
          <volume>57</volume>
          <issue>1</issue>
          <fpage>14</fpage>
        </citation>
      </ref>
      <ref id="bib31">
        <label>Humeau et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Humeau</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Koitka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Saumet</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>L'Huillier</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Spectral components of laser Doppler flowmetry signals recorded in healthy and type 1 diabetic subjects at rest and during a local and progressive cutaneous pressure application: scalogram analyses</article-title>
          <source>Phys. Med. Biol.</source>
          <year>2004</year>
          <volume>49</volume>
          <issue>17</issue>
          <fpage>3957</fpage>
          <lpage>3970</lpage>
          <pub-id pub-id-type="pmid">15470916</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>Ignarro, 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ignarro</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>Experimental evidences of nitric oxide-dependent vasodilatory activity of Nebivolol, a third generation beta-blocker</article-title>
          <source>Blood Press</source>
          <year>2004</year>
          <volume>13</volume>
          <fpage>2</fpage>
          <lpage>16</lpage>
          <comment>Suppl.</comment>
        </citation>
      </ref>
      <ref id="bib33">
        <label>Intaglietta, 1989</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Intaglietta</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Vasomotion and flow modulation in the microcirculation</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Intaglietta</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Progress in Applied Microcirculation</source>
          <volume>Vol. 15</volume>
          <year>1989</year>
          <publisher-name>Karger</publisher-name>
          <publisher-loc>Basel</publisher-loc>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </citation>
      </ref>
      <ref id="bib34">
        <label>Johnson, 1991</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>P.C.</given-names>
            </name>
          </person-group>
          <article-title>The myogenic response</article-title>
          <source>News Physiol. Sci.</source>
          <year>1991</year>
          <volume>6</volume>
          <fpage>41</fpage>
          <lpage>42</lpage>
        </citation>
      </ref>
      <ref id="bib35">
        <label>Kastrup et al., 1989</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kastrup</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>B&#xFC;hlow</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lassen</surname>
              <given-names>N.A.</given-names>
            </name>
          </person-group>
          <article-title>Vasomotion in human-skin before and after local heating recorded with laser Doppler flowmetry &#x2014; a method for induction of vasomotion</article-title>
          <source>Int. J. Microcirc. Clin. Exp.</source>
          <year>1989</year>
          <volume>8</volume>
          <fpage>205</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="pmid">2659545</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <label>Katz et al., 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Hryniewicz</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hriljak</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Balidemaj</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dimayuga</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hudaihed</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yasskiy</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>310</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">15655134</pub-id>
        </citation>
      </ref>
      <ref id="bib37">
        <label>Katz et al., 1999</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zeballos</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Matthew</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Potharlanka</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Knecht</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Whelan</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Decreased activity of the l-arginine&#x2013;nitric oxide metabolic pathway in patients with congestive heart failure</article-title>
          <source>Circulation</source>
          <year>1999</year>
          <volume>99</volume>
          <fpage>2113</fpage>
          <lpage>2117</lpage>
          <pub-id pub-id-type="pmid">10217650</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <label>Killip, 1962</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Killip</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Oscillation of blood flow and vascular resistance during Mayer waves</article-title>
          <source>Circ. Res.</source>
          <year>1962</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>987</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="pmid">14032613</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <label>Kitney et al., 1985</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitney</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Fulton</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Linkens</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Transient interactions between blood-pressure, respiration and heart-rate in man</article-title>
          <source>J. Biomed. Eng.</source>
          <year>1985</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>217</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">4033097</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <label>Kuvin and Karas, 2003</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuvin</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Karas</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>Clinical utility of endothelial function testing. Ready for prime time?</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>107</volume>
          <fpage>3243</fpage>
          <lpage>3247</lpage>
          <pub-id pub-id-type="pmid">12835407</pub-id>
        </citation>
      </ref>
      <ref id="bib41">
        <label>Kvandal et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kvandal</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Landsverk</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Low frequency oscillations of the laser Doppler perfusion signal in human skin</article-title>
          <source>Microvasc. Res.</source>
          <year>2006</year>
          <volume>72</volume>
          <fpage>120</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">16854436</pub-id>
        </citation>
      </ref>
      <ref id="bib42">
        <label>Kvandal et al., 2003</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kvandal</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Veber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostaglandines</article-title>
          <source>Microvasc. Res.</source>
          <year>2003</year>
          <volume>65</volume>
          <fpage>160</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">12711257</pub-id>
        </citation>
      </ref>
      <ref id="bib43">
        <label>Kvernmo et al., 1998</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bra&#x10D;i&#x10D;</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Kvernebo</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Spectral analysis of the laser Doppler perfusion signal in human skin before and after exercise</article-title>
          <source>Microvasc. Res.</source>
          <year>1998</year>
          <volume>56</volume>
          <issue>3</issue>
          <fpage>173</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="pmid">9828155</pub-id>
        </citation>
      </ref>
      <ref id="bib44">
        <label>Kvernmo et al., 2003</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Enhanced endothelial activity reflected in cutaneous blood flow oscillations of athletes</article-title>
          <source>Eur. J. Appl. Physiol.</source>
          <year>2003</year>
          <volume>90</volume>
          <issue>1&#x2013;2</issue>
          <fpage>16</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">12783233</pub-id>
        </citation>
      </ref>
      <ref id="bib45">
        <label>Kvernmo et al., 1999</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Kvernebo</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Oscillations in the human cutaneous blood perfusion signal modified by endothelium-dependent and endothelium-independent vasodilators</article-title>
          <source>Microvasc. Res.</source>
          <year>1999</year>
          <volume>57</volume>
          <fpage>298</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">10329256</pub-id>
        </citation>
      </ref>
      <ref id="bib46">
        <label>Landsverk et al., 2007</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landsverk</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Kvandal</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>The effects of general anesthesia on human skin microcirculation evaluated by wavelet transform</article-title>
          <source>Anesth. Analg.</source>
          <year>2007</year>
          <volume>105</volume>
          <issue>4</issue>
          <fpage>1012</fpage>
          <lpage>1019</lpage>
          <pub-id pub-id-type="pmid">17898381</pub-id>
        </citation>
      </ref>
      <ref id="bib47">
        <label>Landsverk et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landsverk</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Kvandal</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kjelstrup</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Benko</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kirkeb&#xF8;en</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Human skin microcirculation after brachial plexus block evaluated by wavelet transform of the laser Doppler flowmetry signal</article-title>
          <source>Anesthesiology</source>
          <year>2006</year>
          <volume>105</volume>
          <issue>3</issue>
          <fpage>478</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">16931979</pub-id>
        </citation>
      </ref>
      <ref id="bib48">
        <label>Li et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z.Y.</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Tam</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Mak</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Wavelet analysis of skin blood oscillations in persons with spinal cord injury and able-bodied subjects</article-title>
          <source>Arch. Phys. Med. Rehabil.</source>
          <year>2006</year>
          <volume>87</volume>
          <issue>9</issue>
          <fpage>1207</fpage>
          <lpage>1212</lpage>
          <pub-id pub-id-type="pmid">16935056</pub-id>
        </citation>
      </ref>
      <ref id="bib49">
        <label>Liu et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X.D.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>B.F.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>P.Z.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Spectral analysis of blood perfusion in the free latissimus dorsi myocutaneous flap and in normal skin</article-title>
          <source>Phys. Med. Biol.</source>
          <year>2006</year>
          <volume>51</volume>
          <issue>1</issue>
          <fpage>173</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="pmid">16357439</pub-id>
        </citation>
      </ref>
      <ref id="bib50">
        <label>L&#xF3;pez-Send&#xF3;n et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L&#xF3;pez-Send&#xF3;n</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Swedberg</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>McMurray</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tamargo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Maggioni</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Dargie</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tendera</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Waagstein</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kjekshus</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lechat</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Torp-Pederson</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Expert consensus document on b-adrenergic receptor blockers</article-title>
          <source>Eur. Heart. J.</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>1341</fpage>
          <lpage>1362</lpage>
          <pub-id pub-id-type="pmid">15288162</pub-id>
        </citation>
      </ref>
      <ref id="bib51">
        <label>Mayer, 1876</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayer</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Studien zur Physiologie des Herzens und der Blutgef&#xE4;sse 6. Abhandlung: &#xDC;ber spontane Blutdruckschwankungen</article-title>
          <source>S.-B. Akad. Wiss. Wien, math.-nat. Kl.</source>
          <year>1876</year>
          <volume>74</volume>
          <fpage>302</fpage>
        </citation>
      </ref>
      <ref id="bib52">
        <label>Meyer et al., 1988</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>J.U.</given-names>
            </name>
            <name>
              <surname>Borgstrom</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Lindbom</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Intaglietta</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Vasomotion patterns in skeletal-muscle arterioles during changes in arterial-pressure</article-title>
          <source>Microvasc. Res.</source>
          <year>1988</year>
          <volume>35</volume>
          <issue>2</issue>
          <fpage>193</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="pmid">3367792</pub-id>
        </citation>
      </ref>
      <ref id="bib53">
        <label>Moncada et al., 1991</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moncada</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>R.M.J.</given-names>
            </name>
            <name>
              <surname>Higgs</surname>
              <given-names>E.A.</given-names>
            </name>
          </person-group>
          <article-title>Nitric-oxide &#x2014; physiology, pathophysiology, and pharmacology</article-title>
          <source>Pharmacol. Rev.</source>
          <year>1991</year>
          <volume>43</volume>
          <issue>2</issue>
          <fpage>109</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="pmid">1852778</pub-id>
        </citation>
      </ref>
      <ref id="bib54">
        <label>Morgan et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Hanratty</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>S.M.T.</given-names>
            </name>
            <name>
              <surname>Leahey</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Rooney</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Johnston</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>McVeigh</surname>
              <given-names>G.E.</given-names>
            </name>
          </person-group>
          <article-title>Impaired endothelium-dependent and -independent vasodilation in elderly patients with chronic heart failure</article-title>
          <source>Eur. J. Heart. Fail.</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>901</fpage>
          <lpage>908</lpage>
          <pub-id pub-id-type="pmid">15556052</pub-id>
        </citation>
      </ref>
      <ref id="bib55">
        <label>Morlet, 1983</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Morlet</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Sampling theory and wave propagation</article-title>
          <source>Issues in acoustic signal/image processing and recognition</source>
          <volume>Vol. I</volume>
          <year>1983</year>
          <publisher-name>NATO ASI series, Springer-Verlag</publisher-name>
          <publisher-loc>Berlin</publisher-loc>
          <fpage>233</fpage>
          <lpage>261</lpage>
        </citation>
      </ref>
      <ref id="bib56">
        <label>Morris and Shore, 1996</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms</article-title>
          <source>J. Physiol.-London</source>
          <year>1996</year>
          <volume>496</volume>
          <issue>2</issue>
          <fpage>531</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">8910235</pub-id>
        </citation>
      </ref>
      <ref id="bib57">
        <label>Osol and Halpern, 1985</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Osol</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Myogenic properties of cerebral blood-vessels from normotensive and hypertensive rats</article-title>
          <source>Am. J. Physiol.</source>
          <year>1985</year>
          <volume>249</volume>
          <issue>5</issue>
          <fpage>H914</fpage>
          <lpage>H921</lpage>
          <pub-id pub-id-type="pmid">4061668</pub-id>
        </citation>
      </ref>
      <ref id="bib58">
        <label>Rossi et al., 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Carpi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Di Maria</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Galetta</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Spectral analysis of laser Doppler skin blood flow oscillations in human essential arterial hypertension</article-title>
          <source>Microvasc. Res.</source>
          <year>2006</year>
          <volume>72</volume>
          <issue>1&#x2013;2</issue>
          <fpage>34</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">16797604</pub-id>
        </citation>
      </ref>
      <ref id="bib59">
        <label>Salerud et al., 1983</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salerud</surname>
              <given-names>E.G.</given-names>
            </name>
            <name>
              <surname>Tenland</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nillson</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Oberg</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Rhythmical variations in human &#x2014; skin blood-flow</article-title>
          <source>Int. J. Microc. Clin. Exp.</source>
          <year>1983</year>
          <volume>2</volume>
          <issue>2</issue>
          <fpage>91</fpage>
          <lpage>102</lpage>
        </citation>
      </ref>
      <ref id="bib60">
        <label>Schmidt et al., 1992</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Intaglietta</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Borgstrom</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Periodic hemodynamics in skeletal-muscle during local arterial-pressure reduction</article-title>
          <source>J. Appl. Physiol.</source>
          <year>1992</year>
          <volume>73</volume>
          <issue>3</issue>
          <fpage>1077</fpage>
          <lpage>1083</lpage>
          <pub-id pub-id-type="pmid">1400020</pub-id>
        </citation>
      </ref>
      <ref id="bib61">
        <label>Segal, 2005</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segal</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of blood flow in the microcirculation</article-title>
          <source>Microcirculation</source>
          <year>2005</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>33</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">15804972</pub-id>
        </citation>
      </ref>
      <ref id="bib62">
        <label>Silke, 2006</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silke</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Beta Blockade in CHF: pathophysiological considerations</article-title>
          <source>Eur. Heart. J.</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>C13</fpage>
          <lpage>C18</lpage>
        </citation>
      </ref>
      <ref id="bib63">
        <label>Smith et al., 1996</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hoegler</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X.B.</given-names>
            </name>
            <name>
              <surname>Kobari</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Pritchard</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sessa</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Hintze</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure</article-title>
          <source>Circ. Res.</source>
          <year>1996</year>
          <volume>78</volume>
          <fpage>58</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">8603506</pub-id>
        </citation>
      </ref>
      <ref id="bib64">
        <label>S&#xF6;derstr&#xF6;m et al., 2003</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xF6;derstr&#xF6;m</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Veber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Svensson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of sympathetic nerve activity in skin blood flow oscillations in humans</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <year>2003</year>
          <volume>284</volume>
          <fpage>H1638</fpage>
          <lpage>H1646</lpage>
          <pub-id pub-id-type="pmid">12679328</pub-id>
        </citation>
      </ref>
      <ref id="bib65">
        <label>Stefanovska and Bra&#x10D;i&#x10D;, 1999</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bra&#x10D;i&#x10D;</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Physics of the human cardiovascular system</article-title>
          <source>Contemp. Phys.</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>31</fpage>
          <lpage>55</lpage>
        </citation>
      </ref>
      <ref id="bib66">
        <label>Stefanovska et al., 1999</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bra&#x10D;i&#x10D;</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kvernmo</surname>
              <given-names>H.D.</given-names>
            </name>
          </person-group>
          <article-title>Wavelet analysis of oscillations in the peripheral blood circulation measured by laser Doppler technique</article-title>
          <source>IEEE Trans. Biomed. Eng.</source>
          <year>1999</year>
          <volume>46</volume>
          <fpage>1230</fpage>
          <lpage>1239</lpage>
          <pub-id pub-id-type="pmid">10513128</pub-id>
        </citation>
      </ref>
      <ref id="bib67">
        <label>Stefanovska et al., 1997</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Strle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kro&#x161;elj</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>On the overestimation of the correlation dimension</article-title>
          <source>Phys. Lett. A</source>
          <year>1997</year>
          <volume>235</volume>
          <issue>1</issue>
          <fpage>24</fpage>
          <lpage>30</lpage>
        </citation>
      </ref>
      <ref id="bib68">
        <label>Stewart et al., 2007</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Taneja</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Goligorsky</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Medow</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Noninvasive measure of microvascular nitric oxide function in humans using very low-frequency cutaneous laser Doppler flow spectra</article-title>
          <source>Microcirculation</source>
          <year>2007</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>169</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">17454670</pub-id>
        </citation>
      </ref>
      <ref id="bib69">
        <label>Traube, 1865</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traube</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Ueber periodische Th&#xE4;tigkeits-Aeusserungen des vasomotorischen und Hemmungs-Nerven Zentrums</article-title>
          <source>Zentralbl. Med. Wiss.</source>
          <year>1865</year>
          <volume>56</volume>
          <fpage>881</fpage>
          <lpage>885</lpage>
        </citation>
      </ref>
      <ref id="bib70">
        <label>Udelson, 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Udelson</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Ventricular remodeling in heart failure and the effects of beta blockade</article-title>
          <source>Am. J. Cardiol.</source>
          <year>2004</year>
          <volume>93</volume>
          <fpage>43B</fpage>
          <lpage>48B</lpage>
        </citation>
      </ref>
      <ref id="bib71">
        <label>Urban&#x10D;i&#x10D;-Rovan et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urban&#x10D;i&#x10D;-Rovan</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bernjak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>A&#x17E;man-Juvan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kocijan&#x10D;i&#x10D;</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Skin blood flow in the upper and lower extremities of diabetic patients with and without autonomic neuropathy</article-title>
          <source>J. Vasc. Res.</source>
          <year>2004</year>
          <volume>41</volume>
          <issue>6</issue>
          <fpage>535</fpage>
          <lpage>545</lpage>
          <pub-id pub-id-type="pmid">15528936</pub-id>
        </citation>
      </ref>
      <ref id="bib72">
        <label>Van Campen et al., 1998</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Campen</surname>
              <given-names>L.C.M.C.</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature</article-title>
          <source>J. Cardiovasc. Pharm.</source>
          <year>1998</year>
          <volume>32</volume>
          <issue>Suppl. 1</issue>
          <fpage>S31</fpage>
          <lpage>S35</lpage>
        </citation>
      </ref>
      <ref id="bib73">
        <label>Vanhoutte, 1996</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanhoutte</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Endothelium-dependent responses in congestive heart failure</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>1996</year>
          <volume>28</volume>
          <fpage>2233</fpage>
          <lpage>2240</lpage>
          <pub-id pub-id-type="pmid">8938576</pub-id>
        </citation>
      </ref>
      <ref id="bib74">
        <label>Veber et al., 2004</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bandrivskyy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Clarkson</surname>
              <given-names>P.B.M.</given-names>
            </name>
            <name>
              <surname>McClintock</surname>
              <given-names>P.V.E.</given-names>
            </name>
            <name>
              <surname>Stefanovska</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Wavelet analysis of blood flow dynamics: effect on the individual oscillatory components of iontophoresis with pharmacologically neutral electrolytes</article-title>
          <source>Phys. Med. Biol.</source>
          <year>2004</year>
          <volume>49</volume>
          <issue>8</issue>
          <fpage>N111</fpage>
          <lpage>N117</lpage>
          <pub-id pub-id-type="pmid">15152697</pub-id>
        </citation>
      </ref>
      <ref id="bib75">
        <label>Westerman et al., 1988</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westerman</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Widdop</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Hannford</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Low</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>R.G.D.</given-names>
            </name>
            <name>
              <surname>Kent</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sideris</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yip</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hales</surname>
              <given-names>J.R.S.</given-names>
            </name>
            <name>
              <surname>Stephens</surname>
              <given-names>F.R.N.</given-names>
            </name>
          </person-group>
          <article-title>Laser Doppler velocimetry in the measurement of neurovascular function</article-title>
          <source>Australas. Phys. Eng. Sci. Med.</source>
          <year>1988</year>
          <volume>11</volume>
          <issue>2</issue>
          <fpage>53</fpage>
          <lpage>65</lpage>
        </citation>
      </ref>
      <ref id="bib76">
        <label>Zhao et al., 1996</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Hintze</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow</article-title>
          <source>Clin. Exp. Pharmacol. Physiol.</source>
          <year>1996</year>
          <volume>23</volume>
          <fpage>715</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="pmid">8886496</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Simultaneously measured LDF signals showing how blood flow changes in response to iontophoresis with the two vasodilators. (a) Timing of the 100&#xA0;&#x3BC;A iontophoresis current pulses; (b) blood flow in response to ACh; and (c) in response to SNP.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>(a) The wavelet transform of an LDF skin blood flow signal, illustrating the presence of distinct spectral peaks whose frequencies and amplitudes vary in time. The wavelet coefficients, presented in the time&#x2013;frequency domain, were calculated from the basal flow of a healthy subject at rest. Only a short time section of the transform is presented. (b) A time-average of the wavelet transform showing the division of the frequency scale into six intervals.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Summary of heart and respiration frequencies (a and c) and their variability (b and d) for the three subject groups. 0.01&#xA0;&lt;&#xA0;<italic>p</italic>&#xA0;&lt;&#xA0;0.05 is indicated by &#x204E; and <italic>p</italic>&#xA0;&lt;&#xA0;0.01 by &#x204E;&#x204E;. For an explanation of data presentation and error bars, see text (subsection on <xref rid="sec1" ref-type="sec">statistical analysis and presentation</xref>).</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>The effects of ACh and SNP on the mean value of the blood flow signal and the average spectral amplitude for the CHF and HC subject groups. <italic>p</italic>&#xA0;&lt;&#xA0;0.01 is indicated by &#x204E;&#x204E;. For an explanation of data presentation and error bars, see text (subsection on <xref rid="sec1" ref-type="sec">statistical analysis and presentation</xref>).</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Fig. 5</label>
      <caption>
        <p>The effects of ACh and SNP on the individual oscillatory components in blood flow for the CHF and HC subject groups. (a) Effect of ACh on the absolute spectral amplitude; (b) its effect on the normalised spectral amplitude; (c) effect of SNP on the absolute spectral amplitude; (d) its effect on normalised spectral amplitude. 0.01&#xA0;&lt;&#xA0;<italic>p</italic>&#xA0;&lt;&#xA0;0.05 is indicated by &#x204E; and <italic>p</italic>&#xA0;&lt;&#xA0;0.01 by &#x204E;&#x204E;. For an explanation of data presentation and error bars, see text (subsection on <xref rid="sec1" ref-type="sec">statistical analysis and presentation</xref>).</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>Fig. 6</label>
      <caption>
        <p>Effect of &#x3B2;1-blockers. The absolute spectral amplitude (upper row) and normalised spectral amplitude (lower row) are plotted for: (a, d) the HC group; (b, e) the CHF group prior to treatment; (c, f) the CHF group after treatment with &#x3B2;<sub>1</sub>-blockers. 0.01&#xA0;&lt;&#xA0;<italic>p</italic>&#xA0;&lt;&#xA0;0.05 is indicated by &#x204E; and <italic>p</italic>&#xA0;&lt;&#xA0;0.01 by &#x204E;&#x204E;. For an explanation of data presentation and error bars, see text (subsection on <xref rid="sec1" ref-type="sec">statistical analysis and presentation</xref>).</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>Fig. 7</label>
      <caption>
        <p>Comparison of the three subject groups (HC, CHF and CHF-&#x3B2;) in terms of their ACh and SNP responses. Absolute spectral amplitudes are presented in intervals V and VI for (a) ACh response and (b) SNP response. 0.01&#xA0;&lt;&#xA0;<italic>p</italic>&#xA0;&lt;&#xA0;0.05 is indicated by &#x204E; and <italic>p</italic>&#xA0;&lt;&#xA0;0.01 by &#x204E;&#x204E;. For an explanation of data presentation and error bars, see text (subsection on <xref rid="sec1" ref-type="sec">statistical analysis and presentation</xref>).</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <label>Table 1</label>
      <caption>
        <p>Clinical characteristics of the CHF study population before treatment</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="top">Age, y</th>
            <th valign="top">69&#xA0;&#xB1;&#xA0;10</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top">Sex</td>
            <td valign="top">11 male, 6 female</td>
          </tr>
          <tr>
            <td valign="top">Aetiology of CHF, <italic>n</italic></td>
            <td valign="top"/>
          </tr>
          <tr>
            <td valign="top">&#xA0;Ischaemia</td>
            <td valign="top">6</td>
          </tr>
          <tr>
            <td valign="top">&#xA0;Hypertension</td>
            <td valign="top">2</td>
          </tr>
          <tr>
            <td valign="top">&#xA0;Valvular heart disease</td>
            <td valign="top">3</td>
          </tr>
          <tr>
            <td valign="top">&#xA0;Idiopathic dilated cardiomyopathy</td>
            <td valign="top">6</td>
          </tr>
          <tr>
            <td valign="top">Heart rate, bpm</td>
            <td valign="top">79&#xA0;&#xB1;&#xA0;16</td>
          </tr>
          <tr>
            <td valign="top">Blood pressure, mm Hg</td>
            <td valign="top"/>
          </tr>
          <tr>
            <td valign="top">&#xA0;Systolic</td>
            <td valign="top">141&#xA0;&#xB1;&#xA0;16</td>
          </tr>
          <tr>
            <td valign="top">&#xA0;Diastolic</td>
            <td valign="top">77&#xA0;&#xB1;&#xA0;12</td>
          </tr>
          <tr>
            <td valign="top">Total cholesterol, mmol/l</td>
            <td valign="top">5.0&#xA0;&#xB1;&#xA0;1.2</td>
          </tr>
          <tr>
            <td valign="top">Length of treatment, weeks</td>
            <td valign="top">20&#xA0;&#xB1;&#xA0;10</td>
          </tr>
          <tr>
            <td valign="top">Time to maximum tolerated medication, weeks</td>
            <td valign="top">15&#xA0;&#xB1;&#xA0;6</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Group mean and standard deviation are provided where relevant.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="tbl2">
      <label>Table 2</label>
      <caption>
        <p>Frequency intervals</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="top">Interval</th>
            <th valign="top">Frequency (Hz)</th>
            <th valign="top">Physiological origin</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top">I</td>
            <td valign="top">0.6&#x2013;2.0</td>
            <td valign="top">heartbeat</td>
          </tr>
          <tr>
            <td valign="top">II</td>
            <td valign="top">0.145&#x2013;0.6</td>
            <td valign="top">respiratory activity</td>
          </tr>
          <tr>
            <td valign="top">III</td>
            <td valign="top">0.052&#x2013;0.145</td>
            <td valign="top">intrinsic myogenic activity</td>
          </tr>
          <tr>
            <td valign="top">IV</td>
            <td valign="top">0.021&#x2013;0.052</td>
            <td valign="top">neurogenic (sympathetic) activity</td>
          </tr>
          <tr>
            <td valign="top">V</td>
            <td valign="top">0.0095&#x2013;0.021</td>
            <td valign="top">NO-dependent endothelial activity</td>
          </tr>
          <tr>
            <td valign="top">VI</td>
            <td valign="top">0.005&#x2013;0.0095</td>
            <td valign="top">non-NO-dependent endothelial activity</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-wrap>
</article>
